As healthcare professionals, our role in maintaining the health of our adult patients extends beyond routine check-ups and treatments. Prevention through vaccination plays a crucial role in the overall health management of adults. This article aims to provide an overview of the recent advances in adult vaccination, highlighting the importance of staying updated in this rapidly evolving field.
The recombinant zoster vaccine (RZV) is a significant advancement over the live zoster vaccine (ZVL). RZV, approved in 2017, offers over 90% efficacy and is recommended for adults aged 50 years and above, including those who previously received ZVL. It is administered in two doses, two to six months apart.
The annual influenza vaccine remains a cornerstone of preventive healthcare. Recent advancements have led to the introduction of high-dose and adjuvanted vaccines, providing better protection for older adults. Quadrivalent vaccines, offering protection against an additional B virus strain, have also been introduced.
Changes in pneumococcal vaccination recommendations have been made due to the introduction of the 13-valent pneumococcal conjugate vaccine (PCV13). It is now recommended in a series with the 23-valent pneumococcal polysaccharide vaccine (PPSV23) for adults aged 65 years and above, and for adults with certain risk factors.
The recent approval of a new two-dose hepatitis B vaccine, Heplisav-B, has shown a higher protection rate compared to the three-dose series. It is recommended for adults aged 18 years and older, particularly those at risk of hepatitis B virus infection.
With the rapid advancements in adult vaccination, it is paramount for healthcare professionals to stay updated to provide optimal preventive care. These updates not only offer improved protection against diseases but also enhance the efficiency of vaccine administration, contributing to the overall health of our adult patients.
1.
Toward rapid and comprehensive genetic diagnosis of pediatric cancer through adaptive sequencing
2.
Q&A: Why adolescents and young adults with cancer are falling behind
3.
Fixed-Duration Combo Shows Promise for Relapsed MCL
4.
Hospital receives 300 backpacks designed to help kids get leukemia treatment on the go
5.
A study has developed molecular markers that predict meningioma recurrence.
1.
Ultimate Guide to Oncology Services in the USA
2.
Exploring the Benefits of Teclistamab for Treating Advanced Cancer
3.
Glofitamab: A Breakthrough Therapy for Relapsed/Refractory Mantle Cell Lymphoma
4.
The Importance of Iron Rich Foods in Preventing and Treating Anemia
5.
Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on the First Line Management of ALK+ NSCLC
2.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
4.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation